Literature DB >> 24392120

Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: a meta-analysis.

Qiumei Xu1, Fangfen Yuan2, Xuemei Shen2, Hui Wen1, Wei Li1, Bei Cheng1, Jing Wu2.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is a leading cause of mortality in many countries. Considerable studies have been carried out to investigate the relationship between the C242T and A640G polymorphisms of CYBA gene and CAD, but the results were still inconsistent. Hence we conducted a meta-analysis to clarify the association. METHODS AND
RESULTS: A total of 21 eligible literatures were included in the meta-analysis. We observed a significant decreased risk of CAD for C242T polymorphism in Asian population under an allelic model (OR 0.75; 95% CI 0.67-0.84) and a dominant model (OR 0.69; 95% CI 0.61-0.79), however, in overall population and other population no significant association was revealed. We also found A640G polymorphism may contribute to reducing CAD risk under an allelic model (OR 0.84; 95% CI 0.75-0.93), dominant model (OR0.77; 95% CI 0.64-0.92) and recessive model (OR0.82; 95% CI 0.69-0.97). No publication bias was found.
CONCLUSION: Our meta-analysis confirmed a protective effect of C242T polymorphism on CAD in Asian population and indicated that A640G polymorphism was significantly associated with decreased risk of CAD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24392120      PMCID: PMC3879292          DOI: 10.1371/journal.pone.0084251

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Coronary artery disease (CAD), also namely ischemic heart disease (IHD) or coronary heart disease (CHD), mainly including angina and myocardial infarction (MI), is still a leading cause of mortality in many countries with three-fourths of global deaths due to CAD in the low- and middle-income countries [1]. According to a report issued by the World Health Organization, the CAD death toll was expected to account for 13.4% of the total population death by the year 2030 [2]. The death caused by CAD in men and women aged ≥60 years, is surpassed only by human immunodeficiency virus/acquired immune deficiency syndrome in persons aged 15 to 59 years [3]. Oxidative stress in the vasculature and even the whole body induced by superoxide anion via the NADH/NADPH pathway has been implicated in atherosclerosis which is the basic and initial pathogenesis of CAD [4]–[6]. Besides, evidence has also shown that oxidative stress contributes to the development of cardiovascular diseases by vascular wall remodeling and endothelial dysfunction [7]. Evidence over recent years has indicated that the predominant cellular source of superoxide anion in the context of cardiovascular diseases is the NADPH oxidase family [8], [9], which is a class of membrane-associated enzymes that catalyzes the one electron reduction of oxygen to produce reactive oxygen species (ROS) using NADH or NADPH as the electron donor [10]. Among the components of NADPH oxidase, the p22phox protein, an essential subunit for the activation of the NADPH oxidase [11], is expressed in various cells such as human endothelial cells and vascular smooth muscle cells [12]. In addition, the higher expression of p22phox was found in human atherosclerotic coronary arteries than in non atherosclerotic arteries [13]. P22-phox is encoded by the CYBA gene, which is located on chromosome 16q24 and consists of six exons and five introns [14] with a length of 8.5 kb. A large number of genetic variations of this gene, such as C242T, A640G,-930A/G, -675A/T and C549T polymorphism, have been reported. Among these polymorphisms, the two polymorphisms of C242T and A640G have been extensively studied and considered the most interesting. The C242T polymorphism is located in exon 4 and results in an amino acid substitution (histidine to tyrosine) [14], which leads to a loss of oxidative function and a decreased production of ROS and oxidative stress in the vasculature [15]. An in-vivo study [16] also showed the C242T allele was associated with reduced NAD(P)H oxidase activity in human blood vessels. While the A640G polymorphism is located in 3′ untranslated region (3′UTR) [17] of CYBA gene with no amino acid substitution and has also been found an effect on the ROS generation [18], [19]. It has been assumed that A640G modified the stability of mRNA and translational activity of CYBA through the interaction with other regions of mRNA [18]. Since Inoue first found T allele of the C242T polymorphism might have a protective effect against CAD [20], the association of the CYBA gene C242T polymorphism with CAD has been extensively studied over the last decade, however, the results have been conflicting. Nasti even stated the opposite effect with T allele as a risk factor for CAD [21]. As to the association of CYBA gene A640G polymorphism with CAD, the related studies are relatively fewer, but controversy still exists. For example, Inoue found no association between A640G polymorphism and CAD [20], whereas, Gardemann’s study suggested a protective effect on CAD exerted by the G allele [22]. So we conducted this meta-analysis integrating previous publications to study the association between the two polymorphisms of CYBA gene and CAD.

Materials and Methods

Search Strategy and Identification of Relevant Studies

An extensive literature searching of PubMed, EMBASE, ISI Web of Science and Chinese Wan Fang Data was performed for relevant articles without restricting language from June 1996 to May 2012, using the combinations of the keywords “Coronary artery disease”, “Coronary heart disease”, “ischemic heart disease”, “angina pectoris”, “myocardial infarction”, “Polymorphism”, “CYBA”, “P22phox”, “C242T”, “A640G”, “NADPH oxidase”. References of reviews and retrieved studies were also scanned and request to the author to access to the paper has been also tried. We conducted the meta-analysis and reported its results according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement (Checklist S1). The following inclusion criteria had to be fulfilled: (1) case-control study or large-scale replication study assessing the association between C242T polymorphism, A640G polymorphism and CAD risk as an original study. (2) Numbers of case and control groups or available data for calculating genotypic OR with 95% CI. (3)The CAD cases defined as coronary heart disease (CHD), coronary artery disease (CAD), myocardial infarction (MI), acute myocardial infarction (AMI), or unstable angina (UA).

Data Extraction

All the data were extracted independently by two reviewers who reached a consensus on all of the items. Following information was extracted from the eligible literature: first author’s last name, year of publication, country, ethnic origin of the studied population, definition of cases, number in case and control groups, genotype distributions, male percentage and mean ages in case and control groups.

Statistical Analysis

Pooled effect was calculated for the allelic model, dominant model and recessive model in both C242T polymorphism and A640G polymorphism respectively. Heterogeneity among studies was assessed using Q test [23] and Higgins I 2 [24], and was considered significant when P<0.05 for Q statistic. Then heterogeneity was qualified by I: I = 0%–30%, no or marginal between-study heterogeneity; I = 30%–75%, mild heterogeneity; I = 75%–100%, notable heterogeneity [25]. A fixed effect model (Mantel-Haenszel method) was applied when there is no heterogeneity (P<0.05), otherwise a random effect model (DerSimonian and Laird method) was adopted [26]. A meta-regression model was employed to explore the sources of the heterogeneity [27] and then we carried out stratified analysis by subgroup. Sensitivity analysis was conducted to assess the influence of each study on overall pooled OR, with sequential omission of individual study [28]. Funnel plot and Egger’s test described by Egger et al [29] for funnel plot asymmetry were applied to evaluate the evidence for publication bias. All statistical analyses were carried out with R software (version 15.3) and a probability value of P<0.05 was considered statistically significant.

Results

Characteristics of Included Studies

The study selection process is shown in Figure 1. A comprehensive search identified 86 references. After removing the duplicate literature and reports, a total of 21 publications [20]–[22], [30]–[47] preliminarily fit the inclusion criteria. However, after further examination, we removed Morgan’s study that was a large-scale application study with 1461 participants and 85 genetic variants indicating that none of the variants was unequivocally validated. Since 1 article included two populations, both of them were considered as an independent study. There were totally 21studies included in the meta-analysis. The characteristics of these studies were listed in Table 1. There were 7 studies based on Asian population, 10 studies conducted in Caucasian population and 4 studies from other population, such as Spanish, American. The diagnoses in the included articles were CHD, UA, MI, AMI and CAD. For C242T polymorphism, 20 studies were available with a total of 8845 cases and 6855 controls, while for A640G polymorphism; only 6 studies covered a total of 2399 cases and 1411 controls.
Figure 1

Flow chart of the literature search.

CAD, coronary artery disease.

Table 1

Basic characteristics of the included studies.

StudyYearCountryEthnicityDiseaseGenotypeSample size% of male (case/control)Age mean (case/control)
CaseControl
C242TTTTCCCTTTCCC
Inoue1998JapanAsianCAD226173053148201/2010.70/0.7059.8/54.9
Gardemann1999GermanCaucasianCAD207748751652082261706/4991.00/1.0062.2/61.4
Li1999AmericaOtherCAD277052144247149/1030.77/0.4860/57
Cai1999AustraliaCaucasianCAD65250235136264550/1390.80/0.4756.9/54.5
Saha1999IndiaAsianCHD176643207757126/1540.88/0.9355.2/53.9
Saha1999ChinaAsianCHD323125325139151/1671.00/1.0055.3/54.5
Lee2001KoreanAsianCAD440261149165305/2151.00/1.0056.1/50.2
Stanger2001AustraliaCaucasianCAD15504362415108/451.00/1.0052.9/54.2
Yamada2002JapanAsianMI253191440162428161784/10741.00/1.0062.1/62.0
Zafari2002AmericaOtherCAD21705862618164/520.99/0.9461.7/57.1
Balague2004SpainCaucasianAMI2416124757104/1060.88/0/8950.2/50.4
Murase2004JapanAsianMI/UA2673845170587593/15950.76/0.4850.0/60.6
Fan2006FinlandCaucasianCAD1266172105686250/1520.77/0.5862.0/55.0
Nasti2006ItalyCaucasianCAD3714792259598276/2180.83/0.6865.5/66.2
He MA2007ChinaAsianCAD/MI232531264543565/6090.57/0.5261.9/64.7
Niemiec2007PolandCaucasianCAD258067188566172/1690.67/0.7043.8/34.2
Reyes2008SpainOtherMI/UA4813711947145123304/3150.78/0.7456.0/54.5
Alexey2010RussiaCaucasianCAD349118844187313/1320.54/0.5759.2/55.5
Goliasch2011AustriaCaucasianAMI11474131798299/1920.87/0.9037.3/34.7
Najafi2012ItalyCaucasianCAD234744123224114/680.68/0.3262.8/55.9
A640G GG AG AA GG AG AA
Inoue1998JapanAsianCAD828336807942201/2010.70/0.7059.8/54.9
Gardemann1999GermanCaucasianCAD3137354381412511071486/4991.00/1.0062.2/61.4
Zafari2002AmericaOtherCAD377537132512149/500.99/0.9461.7/57.1
Reyes2008SpainOtherMI/UA104155464816596305/3090.78/0.7456.0/54.5
Goliasch2011AustriaCaucasianAMI234728391035098/1920.87/0.9037.3/34.7
Niemiec2011PolandCaucasianCAD396853407545160/1600.68/0.7643.8/59.3

Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; REM, random-effects model; FEM, fix-effects model.

Flow chart of the literature search.

CAD, coronary artery disease. Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; REM, random-effects model; FEM, fix-effects model.

Results of the Overall Meta-analysis

Figure 2 and Figure 3 summarizes the ORs with corresponding 95% CIs for the association between C242T and A640G polymorphisms in the p22phox gene and the risk for CAD in the allelic, dominant and recessive models. A random-effect model was applied to the allelic model and dominant model in the study of C242T polymorphism and to all the genetic models in the study of A640G polymorphism, while a fixed-effect model was chosen for the recessive model in C242T polymorphism according to the P values for heterogeneity. For both C242T polymorphism and A640G polymorphism, no significant association was observed under all the three genetic models. The results are presented in Table 2.
Figure 2

The forest plots of OR with 95% CI for C242T polymorphism and CAD risk.

OR, Odds ratio; 95% CI, 95% confidence interval; RE, random-effects model; FE, fix-effects model; CAD, coronary artery disease.

Figure 3

The forest plots of OR with 95% CI for A640G polymorphism and CAD risk.

OR, Odds ratio; 95% CI, 95% confidence interval; RE, random-effects model; FE, fix-effects model; CAD, coronary artery disease.

Table 2

Initial pooled estimates and stratified analysis for the association between polymorphisms and CAD.

Genetic ModelNModel for analysisOR (95% CI) P for heterogeneity I 2 (%) P for Egger’s test
C242T
Allelic model20REM0.93(0.82,1.05)<0.000167.880.6768
Asian 7 FEM 0.75(0.67,0.84) 0.0618 52.16 0.6371
Caucasian10FEM1.04(0.95,1.14)0.059948.310.7246
Other3FEM1.09(0.91,1.30)0.340010.750.7679
Dominant model20REM0.89(0.76,1.04)<0.000168.150.9351
Asian 7 FEM 0.69(0.61,0.79) 0.0522 52.30 0.7497
Caucasian10FEM1.04(0.93,1.18)0.068547.860.4538
Other3FEM1.09(0.85,1.40)0.273021.630.8526
Recessive model19FEM1.07(0.92,1.25)0.81810.000.2440
A640G
Allele contrast6REM1.06(0.79,1.43)<0.000186.730.5087
Dominant model6REM1.04(0.69,1.58)<0.000180.750.4531
Recessive model6REM1.14(0.74,1.76)<0.000183.450.4144

Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; REM, random-effects model; FEM, fix-effects model.

The forest plots of OR with 95% CI for C242T polymorphism and CAD risk.

OR, Odds ratio; 95% CI, 95% confidence interval; RE, random-effects model; FE, fix-effects model; CAD, coronary artery disease.

The forest plots of OR with 95% CI for A640G polymorphism and CAD risk.

OR, Odds ratio; 95% CI, 95% confidence interval; RE, random-effects model; FE, fix-effects model; CAD, coronary artery disease. Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; REM, random-effects model; FEM, fix-effects model.

Meta-regression Analysis and Stratified Analysis

To explore the source of heterogeneity, a meta-regression analysis of C242T under the allelic model and the dominant model respectively was performed. We conducted a series univariate model by adding single covariates including ethnicity, publication year, disease, sex and age. In the univariate analysis, only the ethnicity can explain the between-study heterogeneity in allelic model (P = 0.0154, tau reducing from 0.0506 to 0.0335) and dominant model (P = 0.0140, tau reducing from 0.0807 to 0.0518).The meta-regression results were presented at Table S1. After stratified by ethnicity, heterogeneity in the subgroup decreased and a decreased CAD risk was conferred in Asian population both in the allelic model (OR = 0.75, 95% CI = 0.67–0.84) and the dominant model (OR = 0.69, 95% CI = 0.61–0.79). Nonetheless, in Caucasian population and other population, no significant association between C242T and CAD was still found (Table 2).

Sensitivity Analysis

The results for C242T polymorphism showed that none of the studies dramatically affected the combined results under the allelic model and the recessive model, while under the dominant model the overall result changed significantly after removing Nasti’s study [21] with OR(95% CI) changing from 0.89(0.76–1.04) to 0.85(0.73–0.99), though the heterogeneity did not decrease sharply (I = 62.53%) (Table S2).This may be because of the marginal statistical significance and moderate effect of the polymorphism. In the sensitivity analysis on A640G polymorphism, in view of the considerable heterogeneity caused by Reyes’s study [43] which probably resulted from the population admixture in the study, we removed it and found a significant association between A640G and CAD under an allelic model (OR 0.84; 95% CI 0.75–0.93), dominant model (OR 0.77; 95% CI 0.64–0.92) and recessive model (OR 0.82;95% CI 0.69–0.97) ) and no statistically significant heterogeneity existed (Table S2). We will have a more detailed discussion in the following part. The adjusted results were showed in Table 3.
Table 3

Adjusted pooled measure on the relation of A640G polymorphism to CAD after sensitivity analysis.

Genetic modelNModel for analysisOR (95% CI) P for heterogeneity I 2(%) P for Egger’s test
A640G
Allele contrast 5 FEM 0.84(0.75,0.93) 0.0923 49.08 0.0741
Dominant model 5 FEM 0.77(0.64,0.92) 0.2346 35.92 0.1073
Recessive model 5 FEM 0.82(0.69,0.97) 0.1851 40.69 0.0755

Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; FEM, fix-effects model.

Abbreviations: N, Number of studies OR, Odds ratio; 95% CI, 95% confidence interval; FEM, fix-effects model.

Publication Bias

As demonstrated by the funnel plot and the Egger’s test, there was no significant publication bias in any overall meta-analysis with all P for Egger’s test>0.05 (Table 2, Figure 4).
Figure 4

The funnel plots of natural logarithm of OR against inverse standard error in each study.

Discussion

Due to the key role of p22phox in CAD and the conflicting results about the relationship of its polymorphisms and CAD, this meta-analysis was conducted and the following conclusions were drawn: (1) The C242T polymorphism of CYBA gene provided significantly protective effect on CAD in Asian populations under an allelic model (OR 0.75; 95% CI 0.67–0.84) and a dominant model (OR 0.69; 95% CI 0.61–0.79), while no protective effect was found in Caucasian population and other population, just consistent with the results in Di Castelnuovo A, et al’s meta-analysis [48] which provided great reference for our study. (2) A significant association between p22phox gene A640G polymorphism and CAD was found under an allelic model (OR 0.84; 95% CI 0.75–0.93), dominant model (OR 0.77; 95% CI 0.64–0.92) and recessive model (OR 0.82; 95% CI 0.69–0.97). In a Japanese population Inoue [20] firstly found 242T as a decreased risk of CAD. Subsequently, Lee [35] and He [40] confirmed that T variant allele was significantly associated with reduced CAD risk both in Korean and Chinese populations. However, Zafari [31] and Cai [33] negated this conclusion in American and Australian populations respectively. Our meta-analysis, of 19 articles with 20 populations from different ethnic origin containing 8845 cases and 6855 controls, afforded us a much higher possibility to reach the reasonable conclusions, which were just consistent with the results in Fang’s meta-analysis [49]. The T allele had contributed to the reduced NADH-stimulated superoxide production and decreased NAD(P)H oxidase reactivity, with reduced activity (by about 30%) of the phagocytic enzyme after stimulation with phorbol 12-myristate 13-acetate (PMA) [16], [50], indicating a weak protective role, which may account for the Asian population as suggested by our findings. Such conflicting results in Asian populations and non-Asian populations are likely to exist because multiple long-standing risk factors confound the possible effect of this polymorphism on CAD such as diabetes, smoke, hypertension and hypercholesterolaemia. Nevertheless, caution is needed in conclusion drawing due to our limited subgroup samples and attention should be paid to the heterogeneity, which still existed though decreased after a subgroup analysis because of the relatively large meta-analysis and the inevitable between-study heterogeneity. For the first time this meta-analysis was conducted to explore the association between p22phox gene A640G polymorphism and CAD. And interestingly, we found a significant association between A640G and CAD under three genetic models after removing Reyes’s study [43]. In view of the considerable heterogeneity caused by this study and to obtain a stable result, we removed this study for reanalysis which hardly affected the power of our meta-analysis (the sample size dropped from 2399 cases and 1411 controls to 2094 cases and 1102 controls) and thus, the final results can be acceptable. In a functional study, Wyche et al. [50] indeed did not confirm any changes in superoxide production by the A640G polymorphism. However, Gardemann et al. [22] found that the A640G SNP might modify processing or stability of p22phox mRNA or alternatively act as a neutral marker. Schirmer et al. [19] observed a significantly reduced ROS formation with increasing numbers of 640G variant alleles in a study of the functional significance of A640G, suggesting a protective effect of the A640G polymorphism on CAD. All these evidence supported a protective effect of 640G on CAD. Nevertheless, notation should be paid to the results because of the limited samples. In conclusion, this meta-analysis was a renewed and confirmed study to assess the association between C242T polymorphism and CAD. It’s the first time that a meta-analysis was conducted to summarize the relationship of A640G polymorphism and CAD. Our combined results implicated the p22phox gene C242T and A640G SNPs played a vital role in coronary artery disease, collectively confirming a genetic involvement of the two polymorphisms in CAD. Further large and well-designed studies will be needed to clarify the association of the polymorphisms and CAD risk. Additional meta-analysis based on GWAS data will also be essential in the future. The meta-regression analysis for heterogeneity under the allelic model and dominant model of p22phox gene C242T polymorphism. (DOC) Click here for additional data file. Sensitive analysis of pooled OR. (DOCX) Click here for additional data file. PRISMA 2009 Checklist. (DOCX) Click here for additional data file.
  48 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Oxidative stress and atherosclerosis.

Authors:  Uma Singh; Ishwarlal Jialal
Journal:  Pathophysiology       Date:  2006-06-06

3.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease.

Authors:  M C Dinauer; E A Pierce; G A Bruns; J T Curnutte; S H Orkin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD(P)H oxidase p22phox gene and severity of stenosis in coronary arteries.

Authors:  Mohammad Najafi; Behnam Alipoor; Mohammad Shabani; Abdollah Amirfarhangi; Hassan Ghasemi
Journal:  Gene       Date:  2012-03-03       Impact factor: 3.688

Review 5.  Antioxidants and atherosclerotic heart disease.

Authors:  M N Diaz; B Frei; J A Vita; J F Keaney
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

6.  Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase.

Authors:  H Sumimoto; K Hata; K Mizuki; T Ito; Y Kage; Y Sakaki; Y Fukumaki; M Nakamura; K Takeshige
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

7.  The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease.

Authors:  A Maziar Zafari; Madalyn N Davidoff; Harland Austin; Liisa Valppu; George Cotsonis; Bernard Lassègue; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2002-08       Impact factor: 8.401

8.  Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation.

Authors:  Karen Bedard; Homa Attar; Jérôme Bonnefont; Vincent Jaquet; Christelle Borel; Olivier Plastre; Marie-José Stasia; Stylianos E Antonarakis; Karl-Heinz Krause
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

Review 9.  NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases.

Authors:  Gorka San José; Ana Fortuño; Oscar Beloqui; Javier Díez; Guillermo Zalba
Journal:  Clin Sci (Lond)       Date:  2008-02       Impact factor: 6.124

Review 10.  Growing epidemic of coronary heart disease in low- and middle-income countries.

Authors:  Thomas A Gaziano; Asaf Bitton; Shuchi Anand; Shafika Abrahams-Gessel; Adrianna Murphy
Journal:  Curr Probl Cardiol       Date:  2010-02       Impact factor: 5.200

View more
  16 in total

1.  Meta-analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians.

Authors:  Po Hu; Ming-yuan Huang; Xin-yang Hu; Xiao-jie Xie; Mei-xiang Xiang; Xian-bao Liu; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

2.  Association analysis of rs1049255 and rs4673 transitions in p22phox gene with coronary artery disease: A case-control study and a computational analysis.

Authors:  M Mazaheri; M Karimian; M Behjati; F Raygan; A Hosseinzadeh Colagar
Journal:  Ir J Med Sci       Date:  2017-05-04       Impact factor: 1.568

3.  Relationship between C242T polymorphism and arterial stiffness in an apparently healthy population.

Authors:  Y Ji; J Ge; Z Zhu; F Wang; J Jiang; H Cao
Journal:  J Hum Hypertens       Date:  2015-10-15       Impact factor: 3.012

Review 4.  Oxidative Stress in Atherosclerosis.

Authors:  Ajoe John Kattoor; Naga Venkata K Pothineni; Deepak Palagiri; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-09-18       Impact factor: 5.113

Review 5.  CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.

Authors:  Marie José Stasia
Journal:  Gene       Date:  2016-04-02       Impact factor: 3.688

Review 6.  Genetics of coronary artery disease and myocardial infarction.

Authors:  Xuming Dai; Szymon Wiernek; James P Evans; Marschall S Runge
Journal:  World J Cardiol       Date:  2016-01-26

7.  p22phox C242T Single-Nucleotide Polymorphism Inhibits Inflammatory Oxidative Damage to Endothelial Cells and Vessels.

Authors:  Daniel N Meijles; Lampson M Fan; Maziah M Ghazaly; Brendan Howlin; Martin Krönke; Gavin Brooks; Jian-Mei Li
Journal:  Circulation       Date:  2016-05-09       Impact factor: 29.690

8.  Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.

Authors:  BiHong Liao; KeQi Cheng; ShaoHong Dong; HuaDong Liu; ZhengLei Xu
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

9.  Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls.

Authors:  Xian-Ping Hua; Xiao-Dong Zhang; Joey Sw Kwong; Xian-Tao Zeng; Zhen-Jian Zhang; Wan-Lin Wei
Journal:  Ther Clin Risk Manag       Date:  2015-09-23       Impact factor: 2.423

10.  Association of the NAD(P)H oxidase p22 phox gene C242T polymorphism with type 2 diabetes mellitus, diabetic nephropathy, and carotid atherosclerosis with type 2 diabetes mellitus: A meta-analysis.

Authors:  Tao Li; Hai-Feng Xi; Hong-Min Luo; Wen-Xuan Liu; Xia Gao; Dian-Wu Liu; Lei Yang
Journal:  Meta Gene       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.